Nephros (NEPH) Free Cash Flow Growth (1y) (2011 - 2026)
Powered by 
Analysis
Nephros (NEPH) Free Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | 28.87% |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | 69.33% |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | 120.89% |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | 14.12% |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 13.29% |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | 142.84% |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | -0.16% |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | -11.68% |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | -14.34% |
| 10 | Nephros | 48.31 Mn | 43.62 Mn | 4.03 Mn | -31.49% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -31.49% |
| Mar 31, 2026 | -618.94% |
| Dec 31, 2025 | -85.81% |
| Sep 30, 2025 | 115.89% |
| Jun 30, 2025 | 298.40% |
| Mar 31, 2025 | 147.92% |
| Dec 31, 2024 | 577.66% |
| Sep 30, 2024 | -204.18% |
| Jun 30, 2024 | -321.68% |
| Mar 31, 2024 | -343.48% |
| Dec 31, 2023 | -40.00% |
| Sep 30, 2023 | 451.76% |
| Jun 30, 2023 | 119.23% |
| Mar 31, 2023 | 115.07% |
| Dec 31, 2022 | 41.79% |
| Sep 30, 2022 | 81.58% |
| Jun 30, 2022 | -904.27% |
| Mar 31, 2022 | -2,247.44% |
| Dec 31, 2021 | 78.05% |
| Sep 30, 2021 | 49.56% |